Rare variants of NPM1 mutations share a similar molecular background to the common NPM1 type A variant and are associated with similar survival in adults with acute myeloid leukaemia
Authors:
- Valentina SangiorgioVSValentina Sangiorgio
- Alberto Hernández‐SánchezAlberto Hernández‐Sánchez
- Rocco PiazzaRPRocco Piazza
- Lars BullingerLBLars Bullinger
- Carlo Gambacorti‐PasseriniCGCarlo Gambacorti‐Passerini
- Mariarita SciumèMSMariarita Sciumè
- Nicola FracchiollaNFNicola Fracchiolla
- Daniele RamazzottiDRDaniele Ramazzotti
- 10 November 2026
- journal article
- Published by Wiley in British Journal of Haematology
Abstract
No abstract availableFunding Information
- Instituto de Salud Carlos III
This publication has 10 references indexed in Scilit:
- Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AMLBlood, 2024
- Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELNBlood, 2022
- Integrative analysis of drug response and clinical outcome in acute myeloid leukemiaCancer Cell, 2022
- Impact of NPM1 mutation subtypes on treatment outcome in AML: The Lyon-University Hospital experienceLeukemia Research, 2019
- TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesNew England Journal of Medicine, 2016
- Genomic Classification and Prognosis in Acute Myeloid LeukemiaNew England Journal of Medicine, 2016
- Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemiaHaematologica, 2015
- The NPM1 Mutation Type Has No Impact on Survival in Cytogenetically Normal AMLPLOS ONE, 2014
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- Clinical Implications of Non-A-Type NPM1 and FLT3 Mutations in Patients with Normal Karyotype Acute Myeloid LeukemiaActa Haematologica, 2011